PANTHERx® Selected by UCB as part of the Limited Specialty Pharmacy Network for RYSTIGGO®(rozanolixizumab-noli), for the Treatment of Generalized Myasthenia Gravis (gMG)
August 02, 2023
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the...
Read More
PANTHERx Rare Announces Exciting Leadership Changes: New President and Key Hire
June 20, 2023
PITTSBURGH, June 21, 2023 /PRNewswire/ — PANTHERx Rare, the
nation’s leading rare disease pharmacy, is excited...
Read More
PANTHERx Rare Pharmacy Expands Services to Include Dispensing AYVAKIT® (avapritinib) for the Expanded Approval for Treatment of Indolent Systemic Mastocytosis (ISM).
June 19, 2023
Blueprint Medicines recently announced the approval of AYVAKIT® (avapritinib)
for...
Read More
1
2
